Adipose-derived stem cells are acquired from the patient’s own body (autologous). CSN utilizes an IRB approved protocol that yields 10 million – 40 million stem cells. Affiliates of CSN then cryopreserve the cells, expanding hundreds of millions of autologous stem cells. The cells are banked in FDA registered labs and returned to physicians’’ offices under IRB approved protocols. Cell sterility is routinely tested at each step of the process to ensure the best possible product.
These stem cells are being used to treat many neurological conditions, such as multiple sclerosis and Parkinson’s disease. Stromal vascular fraction (SVF) of adipose (fat) tissue is a rich source of mesenchymal stem cells (MSCs).
Stromal vascular fraction is a component of lipoaspirate, which is fat cells obtained from liposuction of excess adipose tissue. Lipoaspirate contains stem cells, which have the capacity for multilineage differentiation. SVFs are being used for many neurological conditions.
Stem cell therapy takes around 4-5 hours. During the procedure, expect:
Adipose tissue yields a much higher number of stem cells than blood or bone marrow. In 200 milliliters of adipose tissue, there are millions of dormant stem cells. Bone marrow only yields thousands. In addition, patients receive their own stem cells, so there is low risk for a reaction or adverse immune event. MSCs have been proven to transform into other types of cells, which mean they can become nerve cells to treat neurological conditions.
Stem cells are infused into the bloodstream, and also, injected into localized tissues. Stem cells are attracted to signals from inflammatory cells. Distressed signals also trigger stem cells to differentiate into other cells. These differentiation cells will integrate with target tissues, such as nerves, cartilage, and bone.
Lindvall O & Kokaia Z (2006). Stem cells for the treatment of neurological disorders. Nature, 441(29).